Bionano

Bionano is a genomic analysis solutions provider that enables researchers and clinicians to uncover answers to challenging questions in biology and medicine. The company’s mission is to transform the world’s understanding of genomes through OGM solutions, diagnostic services, and software. It offers OGM solutions for applications in basic, translational, and clinical research. Through its Lineagen, Inc. d/b/a Bionano Laboratories business, the company also provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorders and other neurodevelopmental conditions. Additionally, it offers an industry-leading platform-agnostic software solution that integrates next-generation sequencing and microarray data, designed to provide analysis, visualization, interpretation, and reporting of copy number variations, single nucleotide variations, and loss of genomic heterozygosity in a unified view. The company also provides nucleic acid extraction and purification solutions using proprietary isotachophoresis technology.